BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3234918)

  • 1. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
    Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
    Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
    [No Abstract]   [Full Text] [Related]  

  • 2. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of SCC antigen assay as a tumor marker].
    Kato H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1057-9. PubMed ID: 2192106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gynecologic malignancies].
    Kato H
    Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study on squamous cell carcinoma-related antigen in pleural effusion].
    Suzuki K; Reshad K; Itoi K; Takahashi Y; Hirata T; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Sep; 26(9):923-30. PubMed ID: 3246784
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
    Umezawa S; Takeshima N; Shimizu Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 11. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm].
    Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
    Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of a flat epithelial antigen and prospects for using it as a marker for squamous cell carcinoma].
    Ievleva ES; Shcherbitskaia IIa; Samratova SS; Marshutina NVa IIa; Pugachev KK
    Biull Eksp Biol Med; 1995 Feb; 119(2):209-11. PubMed ID: 7670057
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of assay of squamous cell carcinoma related antigen in tumors of the reproductive organs.
    Takahashi K; Shirai T; Kijima S; Moriyama M; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1304-12. PubMed ID: 3430020
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.